References
- Sacktor N, Lyles RH, Skolasky R et al. HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990–1998. Neurology56(2), 257–260 (2001).
- Ances BM, Ellis RJ. Dementia and neurocognitive disorders due to HIV-1 infection. Semin. Neurol.27(1), 86–92 (2007).
- Koski L, Brouillette MJ, Lalonde R et al. Computerized testing augments pencil-and-paper tasks in measuring HIV-associated mild cognitive impairment. HIV Med. DOI: 10.1111/j.1468–1293.2010.00910.x (2011) (Epub ahead of print).
- Koski L, Brouillette MJ, Lalonde R et al. Computerized testing augments pencil-and-paper tasks in targeting HIV-associated mild cognitive impariment. Presented at: The 20th Annual Canadian Conference on HIV/AIDS Research. Toronto, Ontario, Canada, 14–17 April 2011.
- Letendre SL, McCutchan JA, Childers ME et al. Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders. Ann. Neurol.56(3), 416–423 (2004).
- Heaton RK, Franklin DR, Ellis RJ et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J. Neurovirol.17(1), 3–16 (2011).
- Carvalhal A, Zipursky AR, Bekele T et al. The impact of cART and CNS penetration effectiveness on neuropsychological outcomes in persons living with HIV: findings from the OHTN cohort study. Presented at: The 20th Annual Canadian Conference on HIV/AIDS Research. Toronto, Ontario, Canada, 14–17 April 2011.
- Letendre S, Marquie-Beck J, Capparelli E et al. Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch. Neurol.65(1), 65–70 (2008).
- Gil DM, Harris M, Hull M, Guillemi S, Robin Hsiung GR. CSF viral load in HIV patients attending a neurocognitive disorder clinic (NDC). Presented at: The 20th Annual Canadian Conference on HIV/AIDS Research. Toronto, Ontario, Canada, 14–17 April 2011.
- Papp E, Hapshari AP, Abozina A et al. Lack of change in mitochondrial funciton of HIV/HAART exposed placentae. Presented at: The 20th Annual Canadian Conference on HIV/AIDS Research. Toronto, Ontario, Canada, 14–17 April 2011.
- Chaworth-Musters TF, Fernandez E et al. Adverse health outcomes in HIV exposed uninfected children (HEU) in British Columbia-CIHR Team Grant in HIV Therapy and Aging(CARMA). Presented at: The 20th Annual Canadian Conference on HIV/AIDS Research. Toronto, Ontario, Canada, 14–17 April 2011.
- Bowes J, Brophy JC, Samson L, Gentile C; Children’s Hospital of Eastern Ontario. Pervasive developmental disorder in antiretroviral- and HIV-exposed, uninfected children. Presented at: The 20th Annual Canadian Conference on HIV/AIDS Research. Toronto, Ontario, Canada, 14–17 April 2011.